Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.908 |
High Similarity |
NPD6232 |
Discontinued |
0.903 |
High Similarity |
NPD7473 |
Discontinued |
0.8922 |
High Similarity |
NPD5844 |
Phase 1 |
0.8882 |
High Similarity |
NPD2801 |
Approved |
0.8704 |
High Similarity |
NPD1934 |
Approved |
0.865 |
High Similarity |
NPD1465 |
Phase 2 |
0.865 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8545 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD3226 |
Approved |
0.8438 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8434 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8424 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8418 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8373 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8314 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8304 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8304 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8272 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8272 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8235 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8204 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8165 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8122 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8114 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8084 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8068 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8036 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8024 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD919 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8011 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7941 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7921 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7901 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7886 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7865 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7849 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD37 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7799 |
Intermediate Similarity |
NPD943 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7747 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7744 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7738 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD920 |
Approved |
0.7735 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7735 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7727 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7696 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.768 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.767 |
Intermediate Similarity |
NPD5711 |
Approved |
0.767 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7669 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7539 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7462 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7455 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7455 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7455 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7442 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.741 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7385 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD1613 |
Approved |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7282 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7278 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7249 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7243 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7239 |
Intermediate Similarity |
NPD411 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7235 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7168 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7135 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7128 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7039
|
Intermediate Similarity |
NPD5353 |
Approved |